261 related articles for article (PubMed ID: 25786394)
1. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
Owen DR; MacAllister R; Sofat R
Clin Pharmacol Ther; 2015 Aug; 98(2):119-21. PubMed ID: 25786394
[TBL] [Abstract][Full Text] [Related]
2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
3. Furosemide in acute decompensated heart failure.
Prescrire Int; 2012 Dec; 21(133):303. PubMed ID: 23373103
[TBL] [Abstract][Full Text] [Related]
4. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
6. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
[TBL] [Abstract][Full Text] [Related]
9. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
Parrinello G; Di Pasquale P; Torres D; Cardillo M; Schimmenti C; Lupo U; Iatrino R; Petrantoni R; Montaina C; Giambanco S; Paterna S
Am Heart J; 2012 Sep; 164(3):351-7. PubMed ID: 22980301
[TBL] [Abstract][Full Text] [Related]
10. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
[TBL] [Abstract][Full Text] [Related]
11. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.
Nieves LC; Mehrtens GM; Pores N; Pickrell C; Tanis J; Satty T; Chuang M; Young TC; Merlin MA
Prehosp Disaster Med; 2015 Feb; 30(1):38-45. PubMed ID: 25592809
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
de Denus S; Rouleau JL; Mann DL; Huggins GS; Cappola TP; Shah SH; Keleti J; Zada YF; Provost S; Bardhadi A; Phillips MS; Normand V; Mongrain I; Dubé MP
Pharmacogenomics J; 2017 Mar; 17(2):192-200. PubMed ID: 26927285
[TBL] [Abstract][Full Text] [Related]
14. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
[TBL] [Abstract][Full Text] [Related]
15. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
Zenuk C; Healey J; Donnelly J; Vaillancourt R; Almalki Y; Smith S
Can J Clin Pharmacol; 2003; 10(4):184-8. PubMed ID: 14712323
[TBL] [Abstract][Full Text] [Related]
16. [Hear failure. Indications for diuretic therapy in general practice].
MMW Fortschr Med; 2003 May; 145(18):55. PubMed ID: 12808825
[No Abstract] [Full Text] [Related]
17. Which dosing of furosemide is better in acute decompensated heart failure?
Jalaba S; Palermo J; Budavari AI
JAAPA; 2017 Mar; 30(3):11-12. PubMed ID: 28221314
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
Afari ME; Aoun J; Khare S; Tsao L
Heart Fail Rev; 2019 May; 24(3):309-313. PubMed ID: 30617666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
